Haemophilia
📧 Sign up to get email alerts when something new happens for Haemophilia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-12-19Clinical Trial Update: A Research Study Investigating Mim8 in People With Haemophilia A [Phase 2]
Phase 2 clinical trial update for Mim8 in Haemophilia A indicates the study has completed.
-
CLINICAL_TRIALS trial_result · 2025-12-08Clinical Trial Update: A Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5) [Phase 3]
A Phase 3 trial FRONTER 5 completed, evaluating the safety of switching from emicizumab to Mim8 in people with Haemophilia A, including thos…
-
CLINICAL_TRIALS trial_result · 2025-11-10Clinical Trial Update: Efficacy, Safety & Utilisation of Nuwiq, Octanate and Wilate in Previously Untreated & Minimally Treated Haemophilia A Patients
Clinical trial update examining the efficacy, safety, and use of Nuwiq, Octanate, and Wilate in previously untreated and minimally treated H…
-
CLINICAL_TRIALS trial_result · 2025-10-14Clinical Trial Update: A Study to Compare the Blood Levels of Mim8 in Healthy Men When Administered With the DV3407-C1 Pen Injector or a Syringe and Cartridge [Phase 1]
This Phase 1 study compares the blood levels of Mim8 in healthy men when administered using the DV3407-C1 Pen Injector versus a syringe and …
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Post-Marketing Surveillance (Use-results Surveillance) With Esperoct®
Post-marketing surveillance update reporting completion of a use-results study of Esperoct (turoctocog alfa pegol) in patients with Haemophi…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-04-10Clinical Trial Update: Gene Therapy Study in Severe Haemophilia A Patients (270-201) [Phase 1, Phase 2]
A Phase 1/2 gene therapy trial (NCT02576795) evaluating valoctocogene roxaparvovec for severe haemophilia A has completed, with results post…
-
CLINICAL_TRIALS trial_result · 2025-01-08Clinical Trial Update: Register of Patients With haEmophilia A tReated With Afstyla®
A patient registry for Haemophilia A patients treated with Afstyla has completed.
-
CLINICAL_TRIALS trial_result · 2024-10-31Clinical Trial Update: Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A [Phase 3]
Phase 3 trial evaluating the safety and efficacy of Turoctocog alfa pegol (N8-GP) in previously untreated patients with Haemophilia A; resul…
-
CLINICAL_TRIALS trial_result · 2024-10-02Clinical Trial Update: A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B
Completed study evaluating real-world usage and effectiveness of Elocta and Alprolix in patients with Haemophilia A or B.
-
CLINICAL_TRIALS trial_result · 2024-07-12Clinical Trial Update: An Observational Study to Evaluate Physical Activity, Bleeding Incidence and Health Related Quality of Life, in Participants With Haemophilia A Without Inhibitors Receiving Standard of Care Treatment
A completed observational study in people with Haemophilia A without inhibitors evaluating physical activity, bleeding incidence, and health…
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Efficacy and Safety of Turoctocog Alfa Pegol (N8-GP) for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A (pathfinder10) [Phase 3]
Phase 3 study evaluating the efficacy and safety of N8-GP (turoctocog alfa pegol) for prophylaxis and treatment of bleeding episodes in prev…
-
CLINICAL_TRIALS trial_result · 2023-12-29Clinical Trial Update: Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B [Phase 3]
Phase 3 trial evaluating the safety and efficacy of Nonacog Beta Pegol (N9-GP) in previously untreated patients with Haemophilia B; results …
-
CLINICAL_TRIALS trial_result · 2021-11-26Clinical Trial Update: A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A [Phase 3]
Phase 3 trial update for Turoctocog alfa pegol (N8-GP) in Haemophilia A completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: A Trial Evaluating Efficacy and Safety of Prophylactic Administration of Concizumab in Patients With Severe Haemophilia A Without Inhibitors [Phase 2]
Phase 2 trial evaluating prophylactic Concizumab in patients with severe haemophilia A without inhibitors has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2020-11-03Clinical Trial Update: BAY81-8973 Pediatric Safety and Efficacy Trial [Phase 3]
Phase 3 pediatric trial assessing BAY81-8973 for safety and efficacy in Haemophilia A has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2020-07-07Clinical Trial Update: Evaluation of Safety Following Immune Tolerance Induction Treatment With Turoctocog Alfa in Patients With Haemophilia A Following Inhibitor Development in NN7170-4213 Trial [Phase 3]
Phase 3 trial update evaluating safety of immune tolerance induction with turoctocog alfa in Haemophilia A patients with inhibitors; study t…
-
CLINICAL_TRIALS trial_result · 2020-04-20Clinical Trial Update: Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A [Phase 3]
Phase 3 trial evaluating safety, efficacy, and pharmacokinetics of NNC 0129-0000-1003 for treatment and prophylaxis in Haemophilia A; study …
-
CLINICAL_TRIALS trial_result · 2020-03-18Clinical Trial Update: Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period [Phase 4]
Phase 4 study assessing side effects during regular injections of Turoctocog alfa (Factor VIII) over 8 weeks in people with Haemophilia A.
-
CLINICAL_TRIALS trial_result · 2020-01-21Clinical Trial Update: Evaluating the Haemostatic Effect of NNC 0129-0000-1003 During Surgical Procedures in Subjects With Haemophilia A. [Phase 3]
Phase 3 trial evaluating the haemostatic effect of NNC 0129-0000-1003 during surgical procedures in patients with haemophilia A.
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: A Multinational, Open-Label, Non-Controlled Trial on Safety, Efficacy and Pharmacokinetics of NNC 0129-0000-1003 in Previously Treated Paediatric Patients With Severe Haemophilia A [Phase 3]
A multinational Phase 3 open-label trial assessed safety, efficacy, and pharmacokinetics of NNC 0129-0000-1003 in previously treated paediat…
-
CLINICAL_TRIALS trial_result · 2019-08-26Clinical Trial Update: Efficacy and Safety of Turoctocog Alfa for Prophylaxis and Treatment of Bleeding Episodes in Previously Treated Chinese Patients With Haemophilia A [Phase 3]
Phase 3 trial evaluating Turoctocog Alfa for prophylaxis and treatment of bleeding episodes in previously treated Chinese patients with Haem…
-
CLINICAL_TRIALS trial_result · 2019-01-30Clinical Trial Update: Evaluating the Pharmacokinetics of NovoEight® (Turoctocog Alfa) in Relation to BMI in Subjects With Haemophilia A [Phase 1]
Phase 1 clinical trial completion evaluating how NovoEight (turoctog alfa) pharmacokinetics relate to BMI in individuals with Haemophilia A.
-
CLINICAL_TRIALS trial_result · 2018-10-30Clinical Trial Update: Safety and Efficacy of Turoctocog Alfa in Prevention and Treatment of Bleeds in Previously Untreated Children With Haemophilia A [Phase 3]
Phase 3 trial assessing safety and efficacy of Turoctocog alfa for prevention and treatment of bleeds in previously untreated children with …
-
CLINICAL_TRIALS trial_result · 2018-05-09Clinical Trial Update: Safety and Efficacy of NNC-0156-0000-0009 After Long-Term Exposure in Patients With Haemophilia B: An Extension to Trials NN7999-3747 and NN7999-3773 [Phase 3]
A Phase 3 extension study reports on long-term safety and efficacy of NNC-0156-0000-0009 in patients with Haemophilia B, supplementing NN799…
-
CLINICAL_TRIALS trial_result · 2018-02-23Clinical Trial Update: Efficacy and Cost Effectiveness of Pharmacokinetic Dosing in Haemophilia A [Phase 4]
Phase 4 trial update evaluating efficacy and cost effectiveness of pharmacokinetic dosing in severe Haemophilia A.